given the opportunity to deliver this memorial lecture, designed to honor the man and his accomplishments, and to pay my own respects to his memory.
One of Duckett Jones' major interests was directed toward the importance of streptocoecal infections in the pathogenesis of rheumatic fever, and it is this aspect of the general problem that will be considered in this lecture. The thesis that infections with group-A hemolytic streptococci are somehow involved in the initiation of the rheumatic process ceased to be debatable some years ago, and it is now accepted as the point of departure in most studies of the disease. The primary effect of this fact on research in the field has been a progressive increase in studies concerned with a detailed examination of the microorganism in an attempt to identify the streptococcal property, or properties, responsible for the genesis of rheumatic fever. Although work of this type of necessity concentrates on the characteristics of the streptococcus itself, it is obvious that the information obtained must ultimately be related to the interaction between microorganism and host if it is to be From The Rockefeller Institute, New York, New York. 488 useful in solving the puzzle of pathogenesis. Thus, when one asks the question: "What is the unique property of the group-A streptococcus that is involved in rheumatic fever?", it is really an abbreviated form of the more complex question: "On the assumption that rheumatic fever results from the tissue response of a susceptible human being to some constituent of the streptococcus, what components of the host response and what constitu-ents of the microorganism are involved, and how do they interact to produce the disease?" The attack on the streptococcus is the most popular and perhaps the most logical first approach to the answer to this question.
Before one proceeds with an evaluation of the fruits of the intensive studies on streptococci, it is pertinent to note one general attribute of the organism that is clearly relevant to the problem of rheumatic fever. Among the known bacterial pathogens, the group-A streptococcus is the only one with an epidemiologic pattern of human infection compatible with the known natural history of rheumatic fever. The observed behavior of streptococcal disease not only conforms well with the age and seasonal incidence and the geographic distribution of rheumatic fever but also provides a logical explanation for the notoriously recurrent nature of the disease. Only an organism capable of causing repeated infections at a relatively high rate of frequency throughout childhood could be responsible for the multiple recurrences of rheumatic fever so commonly observed in the era before prophylaxis. In the case of the group-A streptococcus, this behavior is adequately accounted for by the widespread dissemination of a multiplicity of specific serologic types and the demonstration that any immunity that results Circulation, Volu-me XXIX. April 196i4 from infection is primarily type-specific. The available evidence indicates that, prior to the general use of penicillin therapy, repeated infections were almost invariably caused by a succession of different types of group-A streptococci. It is conceivable also that the repetitive nature of streptococcal infection may be of importance in setting the stage for the first attack of rheumatic fever; that is, an attack of streptococcal pharyngitis may never give rise to rheumatic fever unless it has been preceded by one or more "sensitizing" infections in the past. This is a difficult possibility to establish or to eliminate with certainty, but it has an obvious bearing on the kind of picture we should construct of the pathogenesis of the disease.
The major effort in the search for clues to pathogenesis has been directed toward a detailed dissection and analysis of the group-A streptococcus itself. Out of this effort has emerged so large a body of information that the organism is one of the best known in composition and structure in the bacterial world. It will serve no particular purpose here to give a systematic review of the knowledge that Figure 1 Group-A streptococcal surface.
Circulation, Volume XXIX, Apri 1964 has accumulated concerning the biology of the streptococcus. I should like, however, to remind you of its general nature by summarizing certain of the major aspects.
One of the well-known characteristics of group-A streptococci is their ability to elaborate a wide variety of extracellular products during growth in vitro or in vivo. A current list of those that have been adequately studied is given in table 1. Without an attempt to describe the properties of individual members of this family of substances, it will suffice to say that more than a dozen are now known and that there is ample evidence of the existence of still others that are as yet unidentified. In general, their biological activities are known in terms of some enzyme-like reaction, but their contribution to the genesis of streptococcal disease remains to be defined in explicit terms. That the body must cope with these substances in the course of streptococcal infections is attested by the fact that, with one or two exceptions, all of those listed can induce the formation of specific antibodies which make their appearance during convalescence.
A second well-developed body of information on the streptococcal cell derives from the study of its surface structures. The known elements of these structures are summarized diagrammatically in figure 1. The hyaluronic acid capsule, when present, forms the most exterior layer and surrounds the complex cell wall. The wall is composed essentially of three layers, with the first layer represented by a number of proteins, including the type-specific M protein, distributed on the surface of a tough, protective structure. The major component of this protective structure, and the second layer 4McCARTY of the wall, is the group-specific C carbohydrate. The other component, or third layer of the wall, is the mucopeptide structure common to all bacteria, which imparts rigidity to the wall. Within this outer envelope lies a distinct cytoplasmic membrane made up principally of lipoprotein and possessing a multiplicity of antigens and probably the mechanism for synthesis of many of the substances mentioned thus far. As in the case of the extracellular products, our current knowledge of even the composition of the surface complex is almost certainly incomplete, and in fact one known antigenic component, designated as glycerol teichoic acid, is not depicted in the diagram because it is not attached to an insoluble structure, and its precise localization is unknown. All of the surface components mentioned have been studied in some detail and their relationships to one another analyzed.
The investigation of the group-A streptococ-ctIs has not been limited to an examination of the extracellular products and structural components, and considerable progress has been made in the study of certain biological properties of the organism. For example, it has been shown that a substantial percentage of group-A streptococci occurring in nature are infected with temperate bacteriophages-i.e., they are in the lysogenic state. The implications of this fact are only beginning to be explored, but it has already been demonstrated that the production of two of the extracellular products, erythrogenic toxin and hyaluronidase, are directly influenced by lysogenization. In another area, the development of technics for the preparation and study of L forms and protoplasts of streptococci has added a new dimension to the problem of host-parasite interaction. The L form and protoplast are essentially identical, differing only in the method of preparation, and they represent forms in which the cell wall is completely lacking and the cytoplasmic membrane becomes the external surface and only limiting membrane of the cell. Despite the fragility of these forms, their ability to survive and multiply in certain environments and their total insensitivity to penicillin make their possible role in pathogenic processes a matter of great interest.
A vast literature has accumulated dealing with various facets of these several aspects of streptococcal biology and other related topics, which I have not touched upon directly; but it is no secret that these labors have not resulted in a solution to the problem of pathogenesis of rheumatic fever nor even in the framing of a single, widely accepted hypothesis concerning the mechanisms involved. This is not to say that numerous efforts have not been made to arrive at a satisfactory hypothesis on the basis of available knowledge. Indeed, the overabundance of potential mediators of disease among the numerous biologically active streptococcal substances has led to an embarrassing superfluity of theories incriminating one or another of these substances. All of the several categories of streptococcal research mentioned previously are represented in the various ideas that have been advanced to explain the pathogenesis of rheumatic fever. Among the extracellular products, streptolysin S, streptolysin 0, and streptokinase-to cite some of the more prominent examples-have each formed the basis of one or more theories. Similarly, among the components of the surface complex, the type-specific M protein and group-specific C carbohydrate have been a focus of attention in this connection; and quite recently the occurrence of a protein in the streptococcal cell wall, which cross-reacts immunologically with mammalian heart tissue, has been described, leading quite naturally to another theory of pathogenesis. In another recent development, the newly acquired knowledge of the properties of the streptococcal L form has raised the possibility that the persistent viability of some comparable derivative form, devoid of a cell wall, may be of paramount importance. In addition to these hypotheses based on a single substance or property of the streptococcus, there have also been more complicated notions involving the interaction between two or more different bacterial substances and the host tissue response.
In general, the numerous hypotheses that have been formulated-both published and unpublished-have been advocated by an individual or a small group of workers, and none has gained general currency. It is pertinent to inquire into the reasons for the failure of a convincing theory to emerge from a consideration of the existing data. One obvious possibility is that the key streptococcal substance involved in the genesis of rheumatic fever remains among those that are unidentified and not thus far studied. Alternatively, the answer may lie in some undiscovered biological activity of one of the known substances or some element of the host-tissue response that is not yet understood. However, even if one assumes that all of the information is now available to explain the mechanism involved there are sufficient difficulties blocking the framing and establishment of a satisfactory hypothesis to account for the present state of affairs.
One of these difficulties stems from the conmplexity and diversity of the disease process in rheumatic fever and the apparent necessity of bringing all of the manifestations into the framework of a single unitary mechanism. This is perhaps not an insuperable problem in the case of the major manifestations, carditis and arthritis, since the selective localization of lesions in the heart and joints can be rationalized on more than one basis. However, the plot thickens somewhat when one considers the types of skin lesions that occur in rheumatic fever, and it seems to me that the mystery becomes still deeper when one is faced with the necessity of fitting the symptom of chorea into a general pattern. In this latter instance, the problem involves not only the unusual nature of the tissue in which the lesions occur but also the substantial interval of time, which so commonly separates chorea from the other manifestations of rheumatic fever. If nothing else, these considerations serve to emphasize the rather obvious fact that all aspects of the pathology of the disease must be kept in mind when addressing oneself to the problem of mechanism, and they also point up the need for continuing studies of the host component of the disease in parallel with our concern with the streptococcal factor, Circulation, Volume XXIX, April 1964 A second stumbling block that interferes with the confirmation and establishment of any theory of pathogenesis of rheumatic fever is the great difficulty of obtaining concrete experimental evidence to support its validity. This is in part referable to the lack of any convenient and reliable laboratory model of the disease and is also related to the problem of the complexity of rheumatic fever just discussed, but in any event it represents a practical obstacle that has been a dominant factor in the viability of all the hypotheses that have been formulated. In brief, once one has arrived at a conceptual scheme that appears to be a possible explanation of the mechanism of the disease, how can the necessary evidence be obtained to show that it is not merely compatible with the facts but that it is the actual mechanism operating in nature? The difficulties involved can best be illustrated by citing an example arising from one path of research in our laboratory.
Studies of the group-A streptococcal cell wall revealed, as previously mentioned, that the group-specific C carbohydrate is localized in this structure. It accounts for up to 10 per cent of the dry weight of the whole cell, and is thus in all likelihood the major antigenic component of the organism. There are certain points in favor of its possible participation in the events leading to rheumatic fever that at least encouraged further study of this carbohydrate antigen. In the first place, it is common to all strains of group-A streptococci, a desirable property in view of the apparent lack of distinction among the numerous serologic types in the capacity to induce rheumatic fever. Secondly, the carbohydrate resides in an insoluble and resistant structure which is not readily disposed of by the host tissues, and consequently could provide an explanation for the frequently observed perpetuation of the disease long after the termination of the inciting streptococcal infection.
The results of a more detailed examination of the group-specific carbohydrate yielded additional information of pertinence to this line of reasoning. The polysaccharide, when obtained in soluble and serologically active form by a variety of technics, was found to be composed of only two constituent sugars: rhamnose and N-acetyl glucosamine. It clearly possesses a branched structure, and its serologic specificity is largely dependent on Nacetyl glucosamine residues, which are present as the terminal units on the branches or side-chains. The importance of N-acetyl glucosamine end-groups in the specificity of the carbohydrate was established by demonstrating that serologic activity is destroyed when they are removed enzymatically, even though the rest of the molecule remains intact. A further illustration of their importance comes from the fact that synthetic antigens prepared by coupling p-amino-phenyl-N-acetyl glucosaminide to various proteins cross-react strongly in precipitin reactions with group-A streptococcal rabbit antisera. The azo-protein antigens, differing from the C carbohydrate in all respects except for the N-acetyl glucosamine determinants introduced synthetically, are obviously serologically related to it. It may be inferred from these findings that any macromolecular substance that contains N-acetyl glucosamine in the proper configuration in a terminal position would be likely to cross-react with antibody to the group-A carbohydrate. Since N-acetyl glucosamine is a prominent constituent of glycoproteins and of the mucopolysaccharides of human connective tissue, the possibility arises that in certain situations-perhaps in a minor component of connective tissue or in a major component at some intermediate stage of synthesis or degradation-it may appear in the appropriate terminal position to express this type of crossreactivity.
On the basis of this line of reasoning, we entertained the hypothesis that the following chain of events is involved in the genesis of rheumatic lesions: (1) antibodies are produced to the group-specific carbohydrate following a streptococcal infection and continue to be formed as long as elements of the cell wall remain in the tissues; (2) these antibodies, or a certain fraction of them, crossreact with specific tissue sites, and the interaction results in the development of a focal lesion. The attempts to support this hypothesis experimentally included a re-examination of the antibody response of the rheumatic subject to the group-A carbohydrate. The occurrence of circulating anti-carbohydrate antibodies-at least those of the precipitating variety-proves to be not a very dramatic or highly consistent characteristic of the disease, but for reasons that need not be detailed here this finding could be interpreted as providing evidence either for or against the hypothesis. A more crucial matter is the attempt to demonstrate that the hypothetical cross-reactive tissue component actually exists. By a variety of approaches, we have so far been unable to elicit any evidence for the occurrence of a substance in human tissues in which N-acetyl glucosamine is so situated as to confer a specificity related to that of group-A carbohydrate. From the point of view of the present discussion, it is important to point out that even if we had found it, the evidence would have merely been compatible with the hypothesis; and this would be equally true for most other pieces of evidence that one can visualize as emerging from the experimental pursuit of this lead. It is difficult to define accurately what type of information would be required to establish that this mechanism-or any other proposed mechanism-actually operates in the disease. Certainly the more fragments of independent evidence, each compatible with the hypothesis, that can be obtained from different experimental approaches, the more likely the hypothesis becomes. However, it may well be that final proof will depend on clinical investigation and the demonstration that one can intervene effectively to interrupt the disease process by devising some specific means to block the hypothetical mechanism.
In view of the past history of the efforts to solve the puzzle of rheumatic fever, it would be foolhardy to make any specific predictions about the future. However, since several decades of study of the group-A streptococcus have not brought us to the desired goal, it may be time to pause once again for a critical re-evaluation of the validity of this approach to the problem. Is this concentration on a fundamental investigation of the biology of the streptococcus the best-or even a particularly valuable-way of seeking the key to the relationship of the organism to rheumatic fever? Unquestionably it will take us down many paths that are totally irrelevant, since in this type of investigation one is forced to follow the leads provided by the experimental findings, and there is no basis for arriving at a judgment as to which path is the most promising. One result of this uncertainty is that many new streptococcal substances have been discovered, most of which cannot conceivably be of primary importance in the genesis of rheumatic fever. If any prediction can be safely made on this subject, it is that this approach will lead in the future to the finding of more such substances as well as new phenomena, each of which must be studied in detail in evaluating their pertinence to the production of disease. While this may appear to be a wasteful process, it is important to consider what alternatives there are before discarding it. Certainly one cannot ignore the streptococcus as an essential factor in the initiation of rheumatic fever, and therefore any more direct approach to the study of pathogenesis must be based on some preconceived notion of the mechanism by which the organism acts. It should be clear that there is little basis for such notions, so that the uncertainty of a direct approach is even greater than that of the indirect and, in contrast to the fundamental studies of the organism, the frontal attack has little likelihood of producing significant new information as a by-product. I would like to close, therefore, with a reaffirmation of my faith in the importance of a continuing basic study of the biology of the group-A streptococcus and my conviction that it will ultimately forge the missing links in the streptococcal chain leading to rheumatic fever.
The history of scientific and technical discovery teaches us that the human race is poor in independent thinking and creative imagination. Even when the external and scientific requirements for the birth of an idea have long been there, it generally needs an external stimulus to make it actually happen; man has, so to speak, to stumble right up against the thing before the idea comes.-ALBERT EINSTEIN. Essays in Science. New York, Philosophical Library, Inc., 1934 , p. 92. Circulation, Volume XXIX, April 1964 
